PRICE T ROWE ASSOCIATES INC /MD/

Position in TARA — Protara Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in TARA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$147,005

-$42,149 QoQ

Shares Held

38,483

+6.0% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#62

of 118 holders

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. TARA ranks #268 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$147,005	38,483	+6.0%	Shares	Defined	2026-08-14
2026-03-31	$189,154	36,306	+75.1%	Shares	Defined	2026-05-15
2025-12-31	$110,522	20,736	+26.8%	Shares	Defined	2026-02-17
2025-09-30	$71,135	16,353	0.0%	Shares	Defined	2025-11-14
2025-06-30	$49,549	16,353	-94.9%	Shares	Defined	2025-08-14
2021-03-31	$5,026,191	319,326	-26.4%	Shares	Sole	2021-05-17
2020-12-31	$10,497,407	433,598	-3.2%	Shares	Sole	2021-02-16
2020-09-30	$7,541,405	448,093	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.